Glen Eagle Advisors, LLC Simulations Plus, Inc. Transaction History

Glen Eagle Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Aug 13, 2024	SELL	$38.45 - $55.66 $3,845 - $5,566	-100 Closed	0 $0
Q4 2020 Aug 13, 2024	BUY	$53.26 - $77.18 $5,326 - $7,718	100 New	100 $7.19 Million
Q1 2020 Aug 13, 2024	BUY	$26.79 - $38.99 $2,679 - $3,899	100 New	100 $3.49 Million
Q4 2019 Aug 13, 2024	SELL	$29.07 - $35.63 $5,290 - $6,484	-182 Closed	0 $0
Q3 2019 Aug 13, 2024	BUY	$28.19 - $41.75 $5,130 - $7,598	182 New	182 $6.32 Million

171

16M

11.1K

7.3K

Ticker SLP
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 20,297,700
Market Cap $728M
Description
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which sim...

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Glen Eagle Advisors, LLC with notifications on news.